The PARTNERS clinical trial to evaluate potential treatments for Bundibugyo virus has opened enrolment today for #Ebola patients in the #DRC: www.who.int/news/item/02-07-2026-patient-e...
Even without approved therapeutics, many people are recovering from this disease, but of course, we could save more lives with safe and effective therapeutics in our toolkit.
The PARTNERS trial, established with national authorities and scientific partners in record time, offers real hope that we can deliver concrete results for – and with – the communities at the heart of the outbreak.
All patients who enroll in the trial will receive comprehensive supportive care and close follow-up, whether they are randomized to the treatments or not.
My thanks to @inrb_kinshasa, the Institute of Tropical Medicine in Belgium, and the @UniofOxford, @AfricaCDC and all the partners who have been part of this lifesaving effort.
Once again, the Democratic Republic of the Congo is demonstrating its commitment to science, research and innovation in the face of a health emergency. My gratitude to them.